S SARS-CoV-2 Spike Glycoprotein mRNA

SARS-CoV-2 S protein (RBD, 319-541 aa) antibody (67758-1-Ig)

Streamline your COVID-19 studies with constructs expressing a humanized SARS-CoV-2 Spike Glycoprotein (S) - based on SBI's robust lentivector

SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

mRNA Vaccines - HealthDirect

SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies

Coronavirus (CoV) proteins, Introduction

タンパク質発現システム

JCI Insight - SARS-CoV-2 vaccines: a triumph of science and collaboration

Host interactions with SARS-CoV-2

SARS-CoV-2 S protein (RBD, 319-541 aa) antibody (67758-1-Ig)

Get ACE2 studies, such as for SARS-CoV-2 research, up and running quickly with our ready-to-use HEK293 ACE2 Stable Cell Line

HEK293

Vaccine Research: Searching for COVID Immunity

Streamline your COVID-19 studies with constructs expressing the SARS-CoV-2 nucelocapsid protein (N protein) - based on SBI's robust lentivector

SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector